5 These guidelines align with the American Diabetes Association (ADA) standards of care which also provide strong recommendations based on robust clinical trial data supporting the cardiovascular benefits of GLP-1 RAs, particularly in patients with established cardiovascular disease and chronic kidney disease (CKD)
A secondary symptom, like chest discomfort, might be caused by a complication the drug triggered, such as severe dehydration or an inflammatory response
It sends signals to various receptors throughout the body, including the brain, so it can induce satiety
These cells strongly respond to the well-known hormone receptor drug agonists Semaglutide, Orforglipron, Tirzepatide, and Retatrutide (see figures)
If you have type 2 diabetes and want tirzepatide, the FDA-approved option (Mounjaro) is specifically indicated for your condition and should be discussed with your endocrinologist